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ntegrins are adhesion receptors that are crucial to the
functions of multicellular organisms. Integrin-mediated
adhesion is a complex process that involves both afﬁnity
regulation and cytoskeletal coupling, but the molecular
mechanisms behind this process have remained incom-
pletely understood. In this study, we report that the phos-
phorylation of each cytoplasmic domain of the leukocyte
function-associated antigen-1 integrin mediates different
modes of integrin activation. 
 
 
 
 Chain phosphorylation
on Ser1140 is needed for conformational changes in the
I
 
integrin after chemokine- or integrin ligand–induced acti-
vation or after activation induced by active Rap1
(Rap1V12). In contrast, the 
 
 
 
 chain Thr758 phosphoryla-
tion mediates selective binding to 14-3-3 proteins in re-
sponse to inside-out activation through the T cell receptor,
resulting in cytoskeletal rearrangements. Thus, site-speciﬁc
phosphorylation of the integrin cytoplasmic domains is
important for the dynamic regulation of these complex
receptors in cells.
 
Introduction
 
The heterodimeric cell surface receptors called integrins are
exceptional in that they can function as bidirectional signal-
ing devices, regulating cell adhesion and migration after so-
called inside-out signaling, and they can also signal into the
cell to regulate growth, differentiation, and apoptosis after
ligand binding (Giancotti and Ruoslahti, 1999; Hynes, 2002).
The relatively small intracellular domains of integrins are in-
volved in regulating signaling functions. Recently, separa-
tion of integrin cytoplasmic domains has been postulated as a
mechanism of regulating integrin bidirectional signaling (Vi-
nogradova et al., 2002; Kim et al., 2003; Tadokoro et al.,
2003). Proximal events in the regulation of integrin activa-
tion and outside-in signaling presumably involve the binding
of cytoplasmic molecules to the intracellular tails (Calder-
wood, 2004).
Dynamic adhesion is especially important in the immune
system, where cells need to attach and detach continuously.
The leukocyte function-associated antigen-1
 
 
 
(LFA-1) integrin
(
 
 
 
L
 
 
 
2 or CD11a/CD18) is expressed exclusively in leuko-
cytes and is of fundamental importance to the function of the
immune system (Springer, 1990; Gahmberg, 1997). LFA-1
mediates cell adhesion under various conditions, e.g., during
immunological synapse formation between the T cell and the
antigen-presenting cell and during leukocyte emigration from
the bloodstream into tissues. Whereas T cell receptor (TCR)–
mediated adhesion is slow and sustained, chemokine-induced
adhesion is fast and rapidly reversible. Both affinity-depen-
dent and -independent mechanisms have been postulated as
being important in the regulation of integrin activation (van
Kooyk and Figdor, 2000; Carman and Springer, 2003; Calder-
wood, 2004). These mechanisms are not mutually exclusive,
and different modes of integrin activation may involve differ-
ent mechanisms working alone or together. For example,
TCR-induced activation of LFA-1 has not been shown to in-
volve affinity regulation (conformational changes) in the inte-
grin, but instead has been closely correlated with the spreading
phenotype of T cells and actin cytoskeleton rearrangements
(Stewart et al., 1996, 1998). In contrast, chemokines mediate
rapid conformational changes in LFA-1, as measured by acti-
vation epitope expression with mAbs and the measurement of
soluble ligand binding to the integrin (Weber et al., 1999;
Constantin et al., 2000). Chemokine-induced adhesion also in-
volves the clustering of integrins (Constantin et al., 2000).
Ligands can also induce conformational changes and cluster-
ing of integrins (Cabanas and Hogg, 1993; Li et al., 1995;
Kotovuori et al., 1999; Kim et al., 2004).
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Phosphorylation is a common mechanism for the regula-
tion of surface receptor function and has also been reported in
integrins, but its role in integrin regulation has remained only
partially understood (Fagerholm et al., 2004). LFA-1 is phos-
phorylated on both the 
 
 
 
 and 
 
 
 
 chains, with the 
 
  
 
chain being
constitutively phosphorylated, whereas 
 
  
 
chain phosphorylation
becomes detectable after inside-out stimulation of the integrin
(Hara and Fu, 1986; Chatila et al., 1989; Valmu and Gahmberg,
1995). The 
 
  
 
chain phosphorylation sites have not been
mapped, and their functions are completely unknown. In con-
trast, the 
 
  
 
chain phosphorylation sites are known (Hibbs et al.,
1991; Fagerholm et al., 2002b; Hilden et al., 2003). The main
phosphorylation site after phorbol ester stimulation of cells is
Ser756, but this site is not involved in regulating adhesion
(Hibbs et al., 1991). The threonine triplet (Thr758–760) in the
 
 
 
2
 
 
 
chain is important for adhesion, interactions with the actin
cytoskeleton, and modulation of cell spreading (Hibbs et al.,
1991; Peter and O’Toole, 1995). Interestingly, threonine phos-
phorylation of the 
 
  
 
chain has been reported (Valmu and Gahm-
berg, 1995) and threonine-phosphorylated integrins distribute
preferentially to the actin cytoskeleton in cells (Valmu et al.,
1999a). Additionally, it has been shown that 14-3-3 proteins
from cell lysates interact with a Thr758-phosphorylated 
 
 
 
2 in-
tegrin peptide in vitro (Fagerholm et al., 2002b), but whether
the interaction occurs in vivo or plays a role in adhesion has not
been discovered. In this study, we investigated the role of both
 
 
 
 and 
 
  
 
chain phosphorylations in the regulation of LFA-1–
mediated adhesion.
 
Results
 
 
 
L is phosphorylated on Ser1140 in 
T cells
 
To establish the role of LFA-1 phosphorylation in integrin
regulation, we first mapped the phosphorylation sites in 
 
 
 
L.
Endogenous 
 
 
 
L is phosphorylated in both resting 
 
32
 
P-labeled
T cells and in cells activated by phorbol ester stimulation or
through ligation of the TCR with the antibody OKT3 (Fig. 1 A).
The labeled protein band was subjected to trypsin cleavage
and phosphopeptide mapping, and only one major spot (radio-
active peptide) was detected (Fig. 1 B). The maps from resting
cells and from phorbol ester–activated cells were identical (un-
published data), thus no additional sites were phosphorylated
after cell activation. Identification of the serine phosphoryla-
tion site was made using manual Edman degradation. The ra-
dioactive phosphorylated amino acid was detected as the
fourth residue in the tryptic 
 
 
 
L peptide (Fig. 1 C). This result
indicates that Ser1140 in the 
 
 
 
L cytoplasmic domain is the
target of phosphorylation (Fig. 1 D). To confirm this, we sub-
stituted Ser1140 with Ala. COS-1 cells were transiently trans-
fected with wild-type (wt) 
 
 
 
L and S1140A-
 
 
 
L, together with
wt 
 
 
 
2, and cells were labeled with 
 
32
 
P. The LFA-1 protein was
immunoprecipitated from cell lysates and subjected to SDS-
PAGE analysis and autoradiography. No radioactive labeling
was detected in S1140A-
 
 
 
L transfectants (Fig. 1 E). These
data demonstrate that Ser1140 is the principal 
 
 
 
L phosphory-
lation site.
 
Ser1140 is phosphorylated at a high 
stoichiometry in resting T cells
 
To estimate the stoichiometry of 
 
 
 
L phosphorylation in leuko-
cytes, we generated a phosphospecific antibody capable of recog-
nizing 
 
 
 
L only when it has been phosphorylated on Ser1140. The
antibody was 
 
 
 
L specific because it failed to react with lysates of
Jurkat (J)-
 
 
 
2.7 cells, which are an 
 
 
 
L-deficient Jurkat cell line,
and reacted with the 
 
 
 
L integrin in 
 
 
 
L-transfected J-
 
 
 
2.7 cells
(Fig. 2 A). This antibody was also tested for recognition of im-
munoprecipitated LFA-1 from T cells in the presence of blocking
 
 
 
L unphosphopeptide or phosphopeptide (Fig. 2 B). This phos-
phospecific antibody recognized 
 
 
 
L in the presence of competing
unphosphorylated peptide (to block any interactions mediated by
antibodies that recognize nonphosphorylated forms of the inte-
grins), but in the presence of phosphopeptide no recognition
occurred. Specificity was also confirmed by Western blotting
of immunoprecipitated 
 
 
 
L from cells expressing wt 
 
 
 
L and from
cells where Ser1140 had been mutated to nonphosphorylatable
Ala (Fig. 2 C). The antibody reacted with wt 
 
 
 
L, but not with
S1140A-mutated 
 
 
 
L. Thus, the experiments demonstrated that
the antibody is sequence- and phosphospecific.
We used this phosphospecific 
 
 
 
L antibody to assess the
stoichiometry of 
 
 
 
L phosphorylation. The total amount of
Figure 1. Ser1140 is the phosphorylation site in the  L chain of LFA-1.
(A) The integrin   chain is phosphorylated only after cell stimulation,
whereas the   chain is constitutively phosphorylated. Endogenous integrins
were immunoprecipitated from control cells (C) or okadaic acid–pretreated
(1.5  M), PDBu-activated (200 nM; 30 min), or OKT3-activated (10  g/ml;
60 min) 
32P-labeled human T cells and analyzed by SDS-PAGE and auto-
radiography. The radiolabeled  L bands were also quantified. (B) Phos-
phopeptide map of 
32P-labeled  L digested with trypsin from resting T
cells. (C) The main spot in B (arrow) was subjected to Edman degradation.
The radioactive phosphorylated amino acid was detected as the fourth
residue in the tryptic  L peptide. (D) Sequence of the  L cytoplasmic do-
mains with the Ser1140 phosphorylation site shown in bold. The trypsin
cleavage sites in  L are indicated with vertical lines. (E) COS-1 cells were
transfected with wt  L or S1140A- L, together with wt  2, and 
32P-labeled
LFA-1 was immunoprecipitated and analyzed by SDS-PAGE and autora-
diography. No radioactive band was detected in S1140A- L transfec-
tants.  2 integrins were detected from the same filter by immunoblotting to
demonstrate equal loading. 
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heterodimeric LFA-1 (100%) in T cell lysates was determined
by immunoprecipitation with IB4, an antibody that recognizes
heterodimeric LFA-1 rather than the monomeric 
 
 
 
2 (Fig. 2 D;
Wright et al., 1983). The phosphospecific antibody immuno-
precipitated 
 
 
 
40% of the total heterodimeric 
 
 
 
L from resting
T cells (Fig. 2 D). The remaining 
 
 
 
L from this lysate was im-
munoprecipitated with IB4, but no 
 
 
 
L phosphorylation was
seen in this sample when detected with phosphospecific 
 
 
 
L
antibody. We conclude that a maximum of 40% of 
 
 
 
L is con-
stitutively phosphorylated in T cells.
 
Mutation of Ser1140 of 
 
 
 
L abolishes T 
cell adhesion to ICAM-1 induced by the 
activating antibody MEM-83 and MEM-
83–induced affinity regulation of LFA-1
 
We next generated stable J-
 
 
 
2.7 cell transfectants expressing
wt 
 
 
 
L and S1140A-
 
 
 
L to examine the role of the phosphoryla-
tion site in cells (Fig. 3 A). Mutation of Ser1140 to Ala did not
affect the heterodimerization or cell surface expression of
LFA-1. The phosphospecific 
 
 
 
L antibody was used for the
characterization of the J-
 
 
 
2.7 cell clones. The 
 
 
 
L
 
 
 
chain was
easily detected in J-
 
 
 
2.7 wt 
 
 
 
L cells, whereas no significant
staining of 
 
 
 
L was seen in J-
 
 
 
2.7 S1140A-
 
 
 
L cells with or
without phorbol ester activation (Fig. 3 B).
We went on to study the roles of the 
 
 
 
L phosphorylation
site in cells that were stimulated with different agonists. The
binding of both wt 
 
 
 
L and S1140A-
 
 
 
L transfectants to the im-
mobilized ligand intercellular adhesion molecule (ICAM)-1
was increased by TCR ligation and by phorbol ester treatment,
as compared with resting cells (Fig. 4 A). In contrast, cells ex-
pressing S1140A-
 
 
 
L bound less efficiently to ICAM-1 when
activated by MEM-83. It has been speculated that MEM-83 ac-
tivates LFA-1 binding to ICAM-1 by changing the orientation
of the I domain in the 
 
 
 
L, which leads to conformational
change at the ICAM-1 binding site (Lu et al., 2004). Mg/EGTA
also induces a conformational change, probably at the MIDAS
and ADMIDAS sites of the I-like domain of the 
 
 
 
2 subunit
(Shimaoka et al., 2002). Mg/EGTA increased the 
 
 
 
L-mutated
cell adhesion to ICAM-1, but not as effectively as in wt cells
(Fig. 4 A). These results indicate that 
 
 
 
L phosphorylation
could be involved in LFA-1 conformational changes needed
for integrin binding to ligand, but not in integrin activation in-
duced by TCR ligation and phorbol ester stimulation. The latter
stimuli lead to increased binding of cells to coated ICAM-1,
but previous studies have reported that they did not induce con-
formational changes in the integrin (Cabanas and Hogg, 1993;
Figure 2. Characterization of the phospho-
specific  L-Ser1140 antibody and assessment
of the stoichiometry of  L phosphorylation.
(A) A Ser1140 phosphospecific antibody was
made, as described in Materials and methods,
and used in a Western blot of cell extracts pre-
pared from J- 2.7 cells and wt  L–transfected
J- 2.7 cells. (B) The antibody was tested for
recognition of immunoprecipitated LFA-1 from
T cells in the presence of 25  g/ml of block-
ing unphosphopeptide or 25  g/ml of phos-
phopeptide. An immunoprecipitation was
made with the IB4 antibody, which recognizes
only heterodimeric forms of the  2 integrin.
The blots were stripped and reprobed with anti– 2 integrin antibodies (R2E7B) to demonstrate equal loading. (C) wt  L and S1140A- L integrins were
immunoprecipitated from transiently transfected COS-1 cells, and phosphorylated  L was detected by Western blotting. (D) The stoichiometry of the  L
phosphorylation was estimated using the phosphospecific  L-Ser1140 antibody. The T cell lysates were immunoprecipitated with either the phosphospecific
 L antibody or IB4. The remaining  L from phosphospecific  L immunoprecipitation was immunoprecipitated by IB4. Immunoprecipitates were resolved by
SDS-PAGE and phosphorylated  L was detected.  2 detection was used to demonstrate the total amount of integrin in samples. In the Western blot,
the phosphospecific antibody was used in the presence of unphosphorylated peptide.
Figure 3. Mutation of the Ser1140  L phosphorylation site in J- 2.7
transfectants. (A) Surface expression of integrin LFA-1  2 chains (R7E4
antibody staining) and wt and S1140A- L chains (MEM-83 antibody
staining) in J- 2.7 wt cells and J- 2.7 wt  L and J- 2.7 S1140A- L trans-
fectants  was examined by flow cytometry. As a control, the antibody
OKT3 was used to detect similar amounts of CD3 in all clones. Dotted
lines represent the background fluorescence and solid lines the specific
antibody labeling. (B) LFA-1 in S1140A- L–expressing J- 2.7 cells cannot
be phosphorylated on Ser1140, as detected by the phosphospecific anti-
body against  L.  2 was detected with a blotting antibody to demonstrate
equal loading of LFA-1.JCB • VOLUME 171 • NUMBER 4 • 2005 708
Stewart et al., 1996). Whether a negative charge at position
1140 would be enough to affect adhesion was studied by using
a Ser1140Asp mutation (Fig. 4 A, right). The result showed
that the S/A and S/D mutations worked similarly.
To further study the mechanisms of the different modes of
adhesion, a soluble ICAM-Fc (sICAM-1Fc) binding assay was
used to measure the ligand-binding activity. mAb MEM-83
greatly increased the binding of sICAM-1 to wt  L transfectants
(Fig. 4 B), whereas TCR stimulation had no effect. Importantly,
only minimal sICAM-1 binding was observed for S1140A- L
cells after MEM-83 activation. Affinity modulation of LFA-1
can also be detected using mAb24 (Dransfield and Hogg, 1989).
This epitope was not expressed in resting J- 2.7 transfectants,
but there was enhanced expression on the wt cells after MEM-83
activation (Fig. 4 C). The S1140A mutation abolished MEM-83–
induced expression of the mAb24 epitope (Fig. 4 C). Together,
the J- 2.7 cells expressing nonphosphorylatable S1140A- L
mutant show a marked reduction in ICAM-1 binding and expres-
sion of the high-affinity form of integrin.
The phosphorylation site in  L is involved 
in chemokine- and ligand-induced affinity 
regulation of the integrin
One of the best characterized examples of LFA-1 affinity mod-
ulation is the activation of integrin-dependent leukocyte arrest
and migration through G protein–coupled receptors for chemo-
kines (Constantin et al., 2000). SDF-1 , a CXC chemokine,
has been shown to induce a rapid and transient activation of
LFA-1 in J- 2.7 wt  L cells that can be detected by expression
of the mAb24 epitope (Weber et al., 1999). To determine
whether the S1140A mutation affected chemokine-triggered
mAb24 expression, we stimulated J- 2.7 transfectants with
SDF-1  and studied the mAb24 epitope by immunofluores-
cence. No mAb24 staining was seen in nonstimulated cells
(Fig. 5 A). Mg/EGTA treatment was used as a positive control
to show the ability of transfectants to express the mAb24
epitope (Fig. 5, B and E). After SDF-1  stimulation, clear
staining of mAb24 was detected on the wt  L cells, but not on
the S1140A- L–expressing cells (Fig. 5, C and E).
Furthermore, integrin ligands are known to increase adhe-
sion, probably by affinity modulation (Cabanas and Hogg, 1993;
Kotovuori et al., 1999). sICAM-2 increased the expression of the
mAb24 epitope on wt  L cells, whereas no staining of the
S1140A- L cells was observed (Fig. 5, D and E). Thus, physio-
Figure 4. Effect of mutation of the phosphorylation site in the LFA-1  L
chain on adhesion to ICAM-1 and induction of high-affinity LFA-1. (A) Muta-
tion of  L chain Ser1140 affects adhesion induced by an activating antibody
to LFA-1. J- 2.7 transfectants expressing wt  L or S1140A- L were allowed
to bind to ICAM-1–coated wells without stimulation (control) or after stimula-
tion with 10  g/ml OKT3, 200 nM PDBu, 5 mM MgCl2/1 mM EGTA, or 10
 g/ml MEM-83 in the presence or absence of the  2-blocking antibody
R7E4. (right) Adhesion of S1140A- L and S1140D- L–transfected cells to
ICAM-1 after phorbol ester or MEM-83 stimulation was compared. (B) Effects
of the S1140A mutation on sICAM-1–binding activity of LFA-1. J- 2.7 trans-
fectants were activated with 10  g/ml MEM-83 or control antibody OKT3 in
the presence of 150  g/ml ICAM-1Fc and binding was determined by flow
cytometry. (C) The effects of the S1140A mutation on expression of the  L
activation reporter mAb24 were examined. J- 2.7 cells were incubated with
mAb24 in the presence of MEM-83 or R7E4, and mAb24 expression was
analyzed by flow cytometry. Error bars represent SD.
Figure 5. The Ser1140Ala mutation inhibits mAb24 expression induced by
SDF-1 or ICAM-2. (A) J- 2.7 cells expressing wt  L or S1140A- L. (B) Cells
were activated with 5 mM MgCl2/1 mM EGTA for 30 min. (C) Cells were
activated with 3  g/ml SDF-1  for 2 min; (D) Cells were activated with 10
 g/ml sICAM-2Fc for 30 min, and the high-affinity epitope of LFA-1 was ex-
amined by fluorescence microscopy with mAb24. Bar, 20  m. (E) mAb24
expression was quantified using flow cytometry. Error bars represent SD.PHOSPHORYLATION IS IMPORTANT FOR LFA-1 ACTIVATION • FAGERHOLM ET AL. 709
logical activators of the LFA-1 integrin, which have been shown
to lead to extracellular conformational changes, are not able to
activate integrins with nonphosphorylatable  L chains.
Active Rap1 cannot activate the 
S1140A- L–mutated integrin in cells
The small GTPase Rap1 is a potent activator of LFA-1 that is
needed in different modes of LFA-1 activation, including ac-
tivation from the outside of the cell with divalent cations or
antibodies (Katagiri et al., 2000, 2002; de Bruyn et al., 2002;
Sebzda et al., 2002). Transfection of leukocytes with an active
form of Rap1 (Rap1V12) has been shown to increase LFA-1
affinity, as measured by increased ability to bind sICAM-1
(Katagiri et al., 2003). GFP-Rap1V12 was transfected into J- 2.7
cells stably expressing wt  L or S1140A- L (Fig. 6). The
expression level of Rap1V12 in wt  L– and S1140A- L–
expressing J- 2.7 cells was the same (Fig. 6 A). However,
Rap1V12 was unable to activate the S1140A mutant, even if
increased adhesion of wt  L–expressing cells could be observed
after Rap1V12 transfection (Fig. 6 B).
Thr758-phosphorylated  2 binds 14-3-3 
in vitro and in vivo
Having established the phosphorylation site in  L and its func-
tional characteristics, we focused on the investigation of the  2
polypeptide phosphorylation. Both phorbol ester activation and
TCR ligation induce phosphorylation of the   chain on Thr758
(Hilden et al., 2003), which is the first threonine in the TTT
motif that is important for adhesion and cytoskeletal interac-
tions of the LFA-1 and other integrins (Fig. 7 A; Hibbs et al.,
1991; Peter and O’Toole, 1995; Fagerholm et al., 2004). 14-3-3
proteins from leukocyte lysates have previously been shown to
interact with a synthetic  2 integrin peptide phosphorylated on
Thr758 (Fagerholm et al., 2002b), but whether the binding was
direct or indirect and whether it occurred in cells was not estab-
lished. In this study, we examined the binding of purified 14-3-3
proteins to the phosphorylated integrin cytoplasmic peptides.
The proteins bound specifically to the phosphorylated, but not
to the nonphosphorylated,  2 chain, as examined by peptide
affinity chromatography with nonphosphorylated and Thr758-
phosphorylated  2 chain peptides (Fig. 7 B). 14-3-3 proteins
could be eluted from the affinity column by the peptide
ARAApSAPA, which specifically binds to the phosphopeptide-
binding groove in 14-3-3 (Moorhead et al., 1999), but not by a
control peptide (phospho- L peptide; Fig. 7 B). This shows
that the binding is specific and occurs through the canonical
14-3-3 phosphopeptide binding motif (Fig. 7 B). Phosphorylation
Figure 6. Rap1V12 is unable to activate the Ser1140Ala-mutated integrin
in cells. (A) The expression levels of GFP-Rap1V12 in J- 2.7 cell transfec-
tants is shown. (B) Adhesion to coated ICAM-1 of the transfectants was mea-
sured as described in Materials and methods. Error bars represent SD.
Figure 7. Specific binding of 14-3-3 proteins to Thr758-
phosphorylated  2 integrin in vitro and in vivo. (A) Sequence
of the  2 integrin cytoplasmic domain with the Thr758 phos-
phorylation site shown in bold. (B) Binding of purified yeast
14-3-3 proteins to Thr758-phosphorylated and nonphosphor-
ylated peptides was assessed by peptide affinity chromatog-
raphy and Coomassie staining of eluted proteins. Elution was
performed with SDS, the ARAApSAPA peptide, or a control
peptide (phospho- L peptide). (C) Binding of  2 integrin
from control (C), okadaic acid–pretreated (OA), okadaic
acid–pretreated and phorbol ester–activated (OA   PDBu),
or TCR-ligated (OA   OKT3) Jurkat cell lysates to 14-3-3–
Sepharose or BSA columns. The eluted proteins were de-
tected by Western blotting with  2 integrin antibodies. The
two bands detected in the loading control and stimulated
cells presumably represent precursor and mature forms of the
integrin    chain found in Jurkat cells (Fagerholm et al.,
2002a). (D) Coimmunofluorescence of 14-3-3 (green) and
 2 integrins (red) in untreated (control) human T cells or in
cells activated with phorbol ester (PDBu) on ICAM-1– or poly-
lysine–coated coverslips. Bar, 20  m. (E) Increased binding
between 14-3-3 and  2 in TCR-ligated cells. Endogenous
14-3-3 proteins were immunoprecipitated from human T cell
lysates with a control antibody (C ab) or a 14-3-3 mAb, and
coimmunoprecipitating  2 integrins were detected by Western
blotting with  2 integrin antibodies. Immunoprecipitated
14-3-3 proteins were detected with a 14-3-3 blotting anti-
body to demonstrate equal loading. (F) wt  2 or T758A- 2
transfected COS-1 cell lysates were used in the immunoprecip-
itation performed as in E.JCB • VOLUME 171 • NUMBER 4 • 2005 710
of another major site in the  2 cytoplasmic domain, Ser756, has
previously been shown not to mediate 14-3-3 binding (Fager-
holm et al., 2002b). 
Affinity chromatography with 14-3-3 proteins coupled
to Sepharose showed specific interaction between 14-3-3 and
 2 integrins, which occurred only when cells had been acti-
vated with phorbol ester or TCR ligation (Fig. 7 C). Ligand
binding has been shown to cluster integrins on the cell surface
(Kim et al., 2004). Indeed, in coimmunofluorescence studies,
the 14-3-3 proteins and  2 integrins coclustered in activated
T cells spread on ICAM-1, as shown by the increased yellow
staining in these cells compared with cells on poly-lysine or
nonstimulated cells (Fig. 7 D). Importantly, endogenous 14-3-3
proteins and  2 integrins could be coprecipitated from TCR-
stimulated, but not unstimulated, human T cells (Fig. 7 E).
To confirm the Thr758-dependent association between 14-3-3
and  2, we transfected COS-1 cells with wt  2 or T758A-
mutated  2 and performed coprecipitation experiments with
endogenous 14-3-3 proteins. The transfected Thr758Ala-
mutated integrin showed reduced association with endogenous
14-3-3 proteins in most coimmunoprecipitation experiments
(Fig. 7 F).
Mutation of Thr758 in  2 or blocking of 
14-3-3 binding to the  2 chain reduces 
constitutive COS cell adhesion
Mutation of Thr758 in the  2 chain has previously been shown
to affect adhesion of LFA-1 to ICAM-1 when transfected into
COS cells, where LFA-1 is constitutively active, and into LAD
cells (a B lymphoblastoid cell line lacking LFA-1), where
LFA-1 can be activated with phorbol ester (Hibbs et al., 1991).
We used the COS cell system to investigate the effect of direct
14-3-3 association with the  2 chain without interfering with
activating signals of the integrin and because a T cell model
lacking  2 integrins is currently unavailable.
Phorbol ester did not stimulate LFA-1–mediated adhe-
sion to ICAM-1 in this system, but MEM-83 did have a stimu-
latory effect (Fig. 8 A). As previously reported, the Thr758Ala
mutation significantly reduced the constitutive integrin-medi-
ated adhesion of transfected cells to ICAM-1 (Fig. 8 A).
MEM-83 could still activate the Thr-mutated integrin, albeit to
a lower degree than for wt LFA-1 (Fig. 8 A), showing that acti-
vating conformational changes could still occur for the mutated
integrin. However, when both Ser1140 and Thr758 were mu-
tated, not even MEM-83 could activate the integrin-mediated
adhesion (Fig. 8 A), even if the singly mutated Ser1140Ala- L
together with wt  2 could normally mediate adhesion in COS
cells. Because the S1140A- L–mutated integrin is adhesion
deficient in J- 2.7 cells, but not in COS-1 cells, it is clear that
these cells are not a useful model for studying LFA-1 function
in all cases.
To examine whether the effects of the Thr758 mutation
seen were attributable to the blockage of 14-3-3 proteins from
binding to the integrin, we cotransfected cells with wt LFA-1
integrins and an EGFP-R18wt construct, which blocks 14-3-3
interactions with its cellular ligands by binding to the phos-
phopeptide-binding groove in 14-3-3 (Jin et al., 2004). As a
control, we used a mutant construct that does not bind to
14-3-3 proteins (R18mut). The level of GFP proteins and cell
surface LFA-1 integrins in the EGFP-positive cells was equal
in R18wt and R18mut cells, as examined by flow cytometry
(unpublished data), Western blotting with an anti-GFP anti-
body and an LFA-1 blotting antibody (Fig. 8 B), and immu-
nofluorescence (Fig. 8 C). R18wt cotransfected cells showed
markedly reduced adherence to ICAM-1 (Fig. 8, C and D).
The 14-3-3 proteins have many binding partners among cy-
toskeletal and signaling proteins that might affect adhesion,
and R18 peptides have indeed been shown to alter the cyto-
skeleton in cells that do not express LFA-1 (Jin et al., 2004).
However, when the adhesion of endogenous COS cell inte-
grins to fibronectin was examined there was no difference in
adhesion between R18wt and R18mut-transfected cells (Fig.
8 D, right). Thus, it is likely that 14-3-3 binding to the Thr758-
phosphorylated integrin mediates the effect of Thr758 on cell
adhesion.
Figure 8. Effect of the mutation of Thr758 or blocking 14-3-3 binding to
the  2 chain on adhesion to ICAM-1. (A) Mutation of Thr758 of  2 re-
duces COS cell adhesion to ICAM-1. COS-1 cells were transfected with
wt   L or S1140A- L and wt  2 or Thr758/Ala–mutated  2 integrin
cDNA, and cell adhesion to coated ICAM-1 in the presence of PDBu,
blocking antibody (R7E4), or stimulating antibody (MEM-83) was exam-
ined. (B) Cells were cotransfected with wt LFA-1 integrins and EGFP-R18wt
or EGFP-R18mut constructs. Levels of EGFP proteins and LFA-1 in the trans-
fected cells were examined by Western blotting. (C) Adhesion of COS
cells was visualized by immunofluorescence of EGFP-expressing cells ad-
hering to ICAM-1–coated plates (top). Bar, 100  m. (bottom) EGFP levels
in the transfected cells. (D, left) Total cells adhering to ICAM-1 were also
quantified as described in Materials and methods. (D, right) As a control,
the R18wt- and R18mut-transfected cells were also examined for adhesion
of endogenous COS cell integrins to fibronectin. Error bars represent SD.PHOSPHORYLATION IS IMPORTANT FOR LFA-1 ACTIVATION • FAGERHOLM ET AL. 711
14-3-3 binding to phosphorylated  2 is 
involved in cytoskeletal rearrangements
Neither the wt LFA-1 nor the Thr758Ala mutant of the  2
chain showed any binding of mAb24 in COS cells (Fig. 9 A).
Additionally, phorbol esters and TCR ligation have been re-
ported not to induce sICAM-1 binding or mAb24 expression in
T cells, although cell adhesion to coated ICAM-1 can be
readily detected (Stewart et al., 1996). In contrast, TCR trigger-
ing and phorbol esters have been closely associated with a
spreading phenotype of T cells (Stewart et al., 1996). Further-
more, the TTT motif of the integrin has been closely associated
with actin reorganization events, but not affinity changes, in in-
tegrins (Peter and O’Toole, 1995). Indeed, the Thr758 mutation
was shown to significantly reduce cell spreading on ICAM-1 as
examined by FITC-phalloidin staining of polymerized actin
(Fig. 9 B). In addition, R18wt-transfected cell spreading on
ICAM-1 was almost completely abolished (Fig. 9, C and D).
Quantitation of transfected cell spreading showed that R18wt
and LFA-1 cotransfected cells only spread at later time points,
when other untransfected COS-1 cells started spreading unspe-
cifically on ICAM-1 (Fig. 9 D). The mutant R18 construct did
not block spreading. These results show that 14-3-3 binding to
the phosphorylated  2 integrin is important for integrin effects
on the cell cytoskeleton.
A talin head domain construct can 
activate the Thr758Ala-mutated  2 
integrin in cells
The head domain of the large cytoskeletal protein talin has
been demonstrated to be a major player in activation of differ-
ent integrins, including LFA-1 (Kim et al., 2003; Tadokoro et
al., 2003). It binds directly to the   chains of integrin cytoplas-
mic domains and, presumably, induces a separation of the cy-
toplasmic domains of the   and   chains, which leads to a
conformational change in the extracellular domain (Kim et al.,
2003; Tadokoro et al., 2003). Thus, we examined whether
the effect of the T/A mutation of the  2 chain was attribut-
able to an altered ability of talin to bind to and activate LFA-1.
We cotransfected COS cells with wt or T758A-mutated  2 to-
gether with the F2/F3 domains of the talin head domain. The
expression levels of LFA-1 and the talin head domain construct
were similar in the different transfectants, as measured by
Western blotting (Fig. 10 A) and flow cytometry (unpublished
data). We saw an increase in LFA-1–mediated adhesion to
ICAM-1 in the talin head cotransfected cells as compared with
cells without the talin head (Fig. 10 B), although the occur-
rence of adhesion was somewhat less in T758A- 2–transfected
cells than in the wt controls. The talin head domain, like the
antibody MEM-83, could activate S1140A-mutated  L in the
COS cell system (Fig. 10 B). Thus, in COS-1 cells, affinity-
inducing stimuli of the integrin are also functional for S1140A-
mutated  L, indicating the possibility that a leukocyte-specific
restrictive factor working through the   chain is missing.
Figure 9. Blocking the interaction between 14-3-3 and
 2 integrins abolishes actin reorganization and cell
spreading. (A) COS cells were transfected with wt  2 or
T758A- 2, and the transfected COS cells were examined
for mAb24 expression by flow cytometry as in Fig. 3.
Dotted lines represent background fluorescence and solid
lines represent the mAb24 binding. (B) Cells were al-
lowed to spread on coated ICAM-1. The cells were exam-
ined for F-actin by FITC-phalloidin staining. (C) R18wt or
R18mut was cotransfected with wt LFA-1 into COS-cells,
and cell spreading on ICAM-1 was visualized. Both EGFP
(R18) expression and TRITC-phalloidin staining is shown
from the same cells. Bar, 50  m. (D) Spreading was quan-
tified by counting the percentage of spread transfected
cells at different time points. Error bars represent SD.
Figure 10. The head domain of talin can activate the Thr758Ala-mutated
 2 integrin. (A) COS cells were transfected with wt  2 or T758A- 2 or
S1140A- L mutant constructs, together with HA-tagged talin F2/F3 do-
mains, and the level of protein expression was examined by Western
blotting with an LFA-1 blotting antibody or an anti-HA antibody. (B) COS
cell adhesion of the transfected cells to coated ICAM-1 was examined as
described in Materials and methods. Error bars represent SD.JCB • VOLUME 171 • NUMBER 4 • 2005 712
Discussion
Phosphorylation of the cytoplasmic domains of LFA-1 was ini-
tially reported more than a decade ago (for review see Fager-
holm et al., 2004), but the significance of these phosphorylation
events in integrin regulation has remained unclear. Threonine
phosphorylation of  2 has been reported (Valmu and Gahm-
berg, 1995; Hilden et al., 2003), and it has also been shown that
the threonine triplet in  2 (Thr 758–760) is important for both
adhesion and cytoskeletal reorganization mediated by LFA-1
(Hibbs et al., 1991; Peter and O’Toole, 1995). The stoichiome-
try of the phosphorylation of  2 integrin in phorbol ester–stim-
ulated T cells in the presence of okadaic acid was determined
to be 0.92 mol/mol of protein (Valmu et al., 1999b). Because
several sites become phosphorylated under these conditions it
is clear that each site is phosphorylated at a relatively low level
(Fagerholm et al., 2002b; Hilden et al., 2003). However, in
comparison with receptor tyrosine phosphorylation, low stoi-
chiometry phosphorylations may still play important biological
roles by regulating protein–protein interactions.
 L has been shown to be constitutively phosphorylated in
T cells (Hara and Fu, 1986; Chatila et al., 1989), but the phos-
phorylation site and stoichiometry of  L phosphorylation has
not been assessed. We have now mapped the phosphorylation
site in the  L cytoplasmic domain to Ser1140 and shown that
 40% of surface  L was phosphorylated in T cells. A similarly
high stoichiometry of phosphorylation already found in resting
cells has been shown for the  4 integrin (Han et al., 2001).
In analogy with the  4 integrin, where paxillin binding to the
nonphosphorylated integrin rather than to the phosphorylated
form excludes this adaptor protein from the leading edge of the
cell and thus regulates cell migration (Goldfinger et al., 2003),
constitutive phosphorylation of the  L tail may play profound
roles in spatiotemporal regulation of integrin functions.
By mutating Ser1140, we have shown that the nonphos-
phorylatable LFA-1   chain expressed in a T cell line can no
longer be activated by agents that have previously been demon-
strated to induce high-affinity forms of the integrin; i.e., by an
activating antibody (MEM-83); by ligands or chemokines, as
detected by adhesion to ICAM-1; by sICAM-1 binding; or by
mAb24 that detects the high-affinity form of LFA-1. Thus,
phosphorylated Ser1140 is involved in conformational changes
occurring in LFA-1 in response to several different affinity-
increasing stimuli. One possibility is that the negative charge
induced by phosphorylation could facilitate the separation of
the integrin cytoplasmic tails, leading to a conformational
change in the extracellular domain (Kim et al., 2004; Adair et
al., 2005). However, a Ser-Asp mutation did not lead to a dif-
ferent adhesion phenotype compared with the Ser-Ala muta-
tion, indicating that simply substituting a negatively charged
amino acid for serine is not enough to mimic phosphorylation.
Thus, it is more plausible that the  L phosphorylation site
works through selective binding to some cytoplasmic factor.
The small GTPase Rap1 is an important mediator of vari-
ous modes of LFA-1 activation in leukocytes, including activa-
tion by antibodies and divalent cations (Katagiri et al., 2000,
2002; de Bruyn et al., 2002; Sebzda et al., 2002). Importantly,
Rap1 has been shown to act through the integrin   chain cyto-
plasmic domain and to influence integrin affinity for ICAM-1
(Tohyama et al., 2003). Thus, we wanted to examine the effect
of active Rap1 (Rap1V12) on the nonphosphorylatable
S1140A mutant. Rap1V12 was able to induce binding of wt
 L–transfected, but not mutant- L–transfected, J- 2.7 cells to
coated ICAM-1. The mutated  L may be locked in a low-affinity
conformation that cannot be activated from outside of the cell
by activating antibodies or other activating stimuli that increase
integrin affinity for its ligands. However, it can still be acti-
vated with phorbol ester and TCR stimulation, which do not
(and, if so, only marginally) influence integrin affinity.
Rap1 may be working upstream of the  L phosphoryla-
tion, possibly influencing the binding of some cytoplasmic factor
to the  L cytoplasmic tail. RapL is a Rap1-binding molecule that
can activate LFA-1 and is found in leukocytes (Katagiri et al.,
2003). It will be of future interest to study the effect of RapL in
this system.
It has previously been reported that the 14-3-3 isoforms
   and    from leukocyte lysates associate specifically with a
Thr758-phosphorylated   2 integrin COOH-terminal peptide
(Fagerholm et al., 2002b). We discovered that the  2–14-3-3
interaction is direct. Additionally, we have shown that the
binding occurs in T cells that have been activated by stimuli
that induce phosphorylation of the  2 chain on Thr758, i.e.,
phorbol ester and TCR engagement. Mutation of Thr758 or
blocking of 14-3-3 binding to the  2 integrin by R18 peptides
inhibited cell adhesion to ICAM-1. The Thr758 mutation or
R18 peptide also inhibited integrin-mediated cell spreading on
ICAM-1. Thus, phosphorylation of Thr758, which is induced
by inside-out activating stimuli for the integrin, mediates
binding to 14-3-3 proteins in cells, and this interaction seems
to mediate the effect of the integrin on the cell cytoskeleton.
The 14-3-3 proteins are dimers, and both monomers can inde-
pendently bind to phosphorylated targets either within the same
protein or in different proteins (Tzivion and Avruch, 2002;
MacKintosh, 2004). It is possible that threonine phosphoryla-
tion of CD18 recruits 14-3-3 proteins to the plasma membrane–
cytoskeleton connection and that the 14-3-3s in turn recruit
other proteins to regulate downstream events.
There are increasing amounts of evidence that talin plays
a profound role in activating several integrins, including LFA-1
(Kim et al., 2003; Calderwood, 2004; Smith et al., 2005). The
head domain of talin binds to integrin   chains and induces a
separation of   and   chain cytoplasmic domains. Therefore,
we investigated the ability of the talin head domain construct to
activate the  2-T758A mutant. It could still be activated by the
talin construct in cells, as measured by increased adhesion of
the transfected cells to coated ICAM-1. The talin-binding site
in  3 integrins encompasses the first NPXY motif (Tadokoro
et al., 2003) and corresponds to residues 747–755 in  2, which
precede Thr758. Thus, the mechanism by which Thr758 regu-
lates adhesion is presumably not related to talin.
The cytoskeletal protein  -actinin has been shown to as-
sociate with the  2 tail at a membrane-proximal site, whereas
the COOH-terminal portion of the tail (residues 748–762) in-
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Thr758 with Ala or with the phosphate-mimic Glu stimulates
binding of  -actinin to  2, suggesting that phosphorylation of
 2 on Thr758 does not regulate  -actinin binding (Sampath et
al., 1998). Additionally, deletion of the  -actinin binding site
in  2 does not influence adhesion to ICAM-1. On the other
hand, other proteins may bind to the TTT region and, indeed,
filamin has been shown to do so (Calderwood et al., 2001).
Thus, it is possible that threonine phosphorylation and 14-3-3
binding may regulate such interactions.
LFA-1 is involved in many different immunological ad-
hesion events. It can be activated by different stimuli and is
regulated both by conformational changes and by cytoskeletal
attachment and clustering. It is now clear that phosphorylation
of both the   and   chains plays a role in the molecular mecha-
nisms involved in the different activation events. However, the
 L and  2 polypeptides play distinctive roles in integrin acti-
vation. The integrin  L chain is constitutively phosphorylated,
and this phosphorylation site (Ser1140) seems to be required
for adhesion events that involve rapid changes in the conforma-
tion and affinity of the integrin heterodimer. In contrast, the
 2-Thr758 phosphorylation that is induced after physiological
triggering of T cells through the TCR works through interac-
tion with 14-3-3 proteins. This form of adhesion is slower and
involves actin reorganization and cell spreading. The contribu-
tion of the different phosphorylation events to overall adhesion
may depend on the context of adhesion and provides the possi-
bility for regulation of both fast, transient adhesive events and
long-term, stable adhesion strengthening.
Materials and methods
Reagents
Phorbol 12,13-dibutyrate (PDBu) was obtained from Sigma-Aldrich.
[
32P]orthophosphate (aqueous solution, 10 mCi/ml, 5,000 Ci/mmol) was
purchased from the Radiochemical Centre (GE Healthcare). Recombinant
human ICAM-1, ICAM-1Fc, and ICAM-2Fc were obtained from R&D Sys-
tems, and fibronectin was obtained from Calbiochem. Sequencing-grade
modified trypsin (activity more than 2.5 U/mg) was purchased from
Promega. G418 was purchased from Calbiochem-Novabiochem. SDF-1
was obtained from R&D Systems. The peptides (ARAApSAPA, CLFK-
SATTTVMN, CLFKSApTTTVMN, and CLKPLHEKDSEpSGGGKD, where pS
is phosphoserine and pT is phosphothreonine) were synthetized by Fmoc
chemistry (Valmu et al., 1999b).
Antibodies
The mAbs R7E4 and R2E7B against the human  2 subunit of leukocyte
integrin have been described previously (Nortamo et al., 1988). The
monoclonal activating antibody against CD3, OKT3, was purified from
ascites fluid produced by hybridoma cells (clone CRL 8001; American
Type Culture Collection). The activating mAb MEM-83 was provided by
V. Horejsi (Institute of Molecular Genetics, Prague, Czech Republic).
IB4 was a gift from M.A. Arnaout (Massachusetts General Hospital,
Boston, MA). mAb24 ( 2) was a gift from N. Hogg (Imperial Cancer
Research Fund, London, UK). The 14-3-3 antibodies H-8 and K-19, as
well as the GFP antibody, were obtained from Santa Cruz Biotechnology,
Inc. The HA-tagged talin F2/F3 protein was detected by anti–HA-biotin
antibodies (Roche) and streptavidin-HRP (GE Healthcare). To produce
antiserum to phospho- L, the integrin  L chain phosphopeptide CLKPL-
HEKDSEpSGGGKD was conjugated to keyhole limpet hemocyanin
(Harlow and Lane, 1988). The complex was injected into rabbits. The
antisera were purified by affinity chromatography using the phosphory-
lated peptide.
cDNA constructs
The EGFP-R18 and EGFP-R18mut plasmids were gifts from T. Pawson
(University of Toronto, Toronto, Canada). The 14-3-3 Saccharomyces
cerevisiae isoforms BMH1 and BMH2 plasmids in DH5  were gifts from
C. MacKintosh (University of Dundee, Nethergate, Dundee, Scotland,
UK). The HA-tagged talin F2/F3 construct was a gift from D. Calder-
wood (Yale University, New Haven, CT). GFP-Rap1V12 was a gift from
D. Cantrell (University of Dundee). cDNA coding for full-length human  L
was subcloned into the pcDNA3 vector and human  2 was subcloned
into the  HM3 vector. Mutants were created using site-directed mutagen-
esis (Weiner et al., 1994), and the mutated constructs were checked by
sequencing.
Cell lines and transfection
Buffy coats used for the isolation of T cells were obtained from the Finnish
Red Cross Blood Transfusion Service (Valmu et al., 1999b). The cells were
grown in RPMI 1640 medium supplemented with 10% FCS, L-glutamine,
and antibiotics. The Jurkat cell clone E6.1 (American Type Culture Collection)
was maintained in the same medium.
COS-1 cells were cultured in DME supplemented with 10% FCS,
L-glutamine, and antibiotics. COS-1 cells were used for transient expres-
sion of wt and mutant  2 integrins. COS-1 cells were cotransfected with
purified   - and  -subunit cDNAs with or without EGFP-R18wt, EGFP-
R18mut, or talin F2/F3 constructs using the FuGENE 6 transfection reagent
according to the manufacturer’s instructions (Roche). Flow cytometric
analysis was used to quantify cell surface expression of integrins in the
transfected COS-1 cells.
The human T lymphoma cell line clone J- 2.7, which lacks the LFA-1
  chains and was derived from Jurkat cells by mutagenesis (Weber et al.,
1997), was a gift from N. Hogg. J- 2.7 cells (7.2   10
6 per transfection)
were washed, suspended in 0.36 ml PBS, and mixed with 20  g wt  L or
S1140A- L DNA. Electroporation was performed at 240 V and 950  F.
After 48 h of culture, the medium was supplemented with 0.8 mg/ml
G418. LFA-1–expressing cells were enriched using magnetic cell sorting
(Miltenyi Biotec GmbH). Alternatively, cells (S1140D- L and Rap1V12)
were transfected with the Optifect system according to the manufacturer’s
instructions (Invitrogen). Flow cytometric analysis was used to quantify cell-
surface expression of integrins in the transfected cells. For both wt  L– and
S1140A- L–expressing J- 2.7 cells, several clones were selected that
exhibited comparable levels of surface expression as detected by flow
cytometry. In each experiment, we used two independent clones of both
wt and  L mutant cells.
Peptide affinity chromatography
The peptides CLFKSATTTVMN and CLFKSApTTTVMN, corresponding to
the  2 integrin sequence surrounding the phosphorylated Thr758, were
coupled to thiopropyl–Sepharose according to the manufacturer’s instruc-
tions. His-tagged BMH1 and BMH2 proteins were expressed in Escherichia
coli DH5  and purified with Ni-NTA columns (Moorhead et al., 1999).
Affinity chromatography was performed with 2  g each of purified 14-3-3
proteins BMH1 and BMH2. After extensive washes, the bound proteins
were eluted either with SDS or with 1 mM ARAApSAPA peptide or 1 mM
phospho- L peptide (CLKPLHEKDSEpSGGGKD), and the eluates were run
on SDS-PAGE and stained with Coomassie blue.
14-3-3 affinity chromatography
Purified BMH1 and BMH2 or BSA were coupled to Sepharose (Moorhead
et al., 1999). Jurkat cells were either left untreated or stimulated with 1.5
 M of okadaic acid, a combination of okadaic acid and the OKT3 anti-
body (10  g/ml) against the TCR, or 200 nM PDBu. The cells were lysed
as described previously (Valmu et al., 1999b). The lysates were mixed
with the affinity matrix for 1 h and washed extensively with 500 mM
NaCl. Bound proteins were eluted with SDS and analyzed by Western
blotting with the blotting  2 integrin antibody R2E7B.
Coimmunoprecipitation
Human T cells were activated with OKT3 or left untreated. Cells were
lysed as described previously (Valmu et al., 1999b) and lysates were pre-
cleared with protein G–Sepharose. Immunoprecipitations were made with
the 14-3-3 H8 antibody or control antibody (OKT3) coupled to protein
G–Sepharose, and the immunoprecipitates were washed four times with
lysis buffer. The bound proteins were eluted with SDS and analyzed by
Western blotting with a 14-3-3 antibody (K-19) and  2 integrin antibody
(R2E7B).
Cell adhesion assays
Recombinant soluble human ICAM-1 or fibronectin (0.3  g/well) was
coated on flat-bottom 96-well microtiter plates by overnight incubation at
4 C. The wells were blocked with 1% dry milk for 1.5 h at 37 C. CellsJCB • VOLUME 171 • NUMBER 4 • 2005 714
were suspended in binding medium (DME for COS-1 and RPMI 1640 for
J- 2.7 cells, with 40 mM Hepes, 0.1% BSA, and 1–2 mM MgCl2). Cells
were stimulated with either 200 nM PDBu or 10  g/ml OKT3 or MEM-
83, added to each well, and allowed to adhere for 20 (COS-1) or 30
(J- 2.7) min at 37 C. In inhibition experiments, cells were preincubated
for 15 min with 10  g/ml of the blocking antibody R7E4. After incuba-
tion, unbound cells were removed by gentle washing. The binding was
quantified by ELISA.
Immunofluorescence staining
Human T cells or J- 2.7 cells were seeded onto poly-lysine– or ICAM-1–
coated coverslips at 5   10
5 cells/slide in culture medium in the presence
or absence of activators and incubated for 30–60 min at 37 C. For trans-
fected COS-1 spreading assays, 2   10
5 cells were seeded onto ICAM-1–
coated coverslips and incubated for the times indicated in the figure leg-
ends. Unbound cells were gently washed away and adherent cells were
fixed for 10 min with 1% formaldehyde/PBS. Cells were labeled with
FITC- or TRITC-phalloidin in 0.1% saponin/1% FBS/PBS for 20–30 min,
or cells were incubated with primary antibodies (mAb24, R7E4, 14-3-3
antibody K19 in PBS, or in saponin buffer) for 30 min, followed by incu-
bation with Cy3-conjugated anti–mouse or FITC-conjugated anti–rabbit
antibody. After washing with PBS, coverslips were mounted with Mowiol
mounting medium and observed under a fluorescence microscope (model
IX71; Olympus) and photographed with a camera (model DP70; Olympus).
Images were analyzed and processed using the analySIS program (Soft
Imaging System GmbH) and Adobe Photoshop.
32P radiolabeling and cell activation, immunoprecipitation, and SDS-PAGE
32P cell labeling was done as previously described (Valmu et al., 1999b).
T cells were labeled overnight and COS-1 cells were labeled for 2 h at
37 C. After labeling, the cells were activated or left untreated. The T cell
activation was stopped by adding ice-cold 10 mM EDTA/PBS, and COS-1
cells were detached with 5 mM EDTA/PBS. The cells were washed and
lysed as described previously (Valmu et al., 1999b). The intensity of the
radiolabeled bands was quantified using the Tina 2.09c software (Raytest).
The intensity of the radiolabeled bands was reported as intensity of the
band minus background intensity of the lane.
Cell lysates were used for immunoprecipitation with 1–3  g R7E4
or IB4 for 2.5 h or overnight and coupled to protein G–Sepharose for 30
min at 4 C. The immunoprecipitates were washed extensively with de-
creasing detergent and salt concentrations. Bound proteins were eluted
with 1% SDS, subjected to SDS-PAGE, and blotted onto polyvinylidene
fluoride membranes (Millipore). Phosphopeptide mapping and manual
radiosequencing of phosphopeptides have been described previously
(Hilden et al., 2003).
Flow cytometric analysis
Cells were incubated with PBS containing 20  g/ml of the indicated an-
tibodies (R7E4, MEM-83, and OKT3) on ice for 30 min. The cells were
then washed with PBS and further incubated with FITC-conjugated anti–
mouse IgG and subjected to flow cytometric analysis with FACScan
(Becton Dickinson). For mAb24 staining, J- 2.7 cells or COS-cells were
reacted with 10  g/ml mAb24 in the presence of the activating anti-
body 10  g/ml MEM-83 for 30 min at 37 C. Cells were instantly
stained with FITC-conjugated anti–mouse IgG antibodies on ice for 20
min and analyzed by flow cytometry. mAb24 expression was reported
as mean fluorescence intensity.
sICAM-1Fc binding assay
J- 2.7 transfectants were incubated in 25  l RPMI 1640, 40 mM Hepes,
and 1 mM MgCl2 in the presence or absence of stimulators and 150  g/ml
ICAM-1Fc at 37 C for 30 min. After removal of the unbound ligand by
washing with PBS, the cells were incubated with FITC-conjugated anti–
human IgG-Fc–specific antiserum (Jackson ImmunoResearch Laboratories)
on ice for 20 min. Cells were analyzed by flow cytometry.
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